COMPANY HISTORY
LBR Regulatory and Clinical Consulting Services and Innovative Analytics (IA)
COMPANY HISTORY
LBR Regulatory and Clinical Consulting Services and Innovative Analytics (IA)
LBR Regulatory and Clinical Consulting Services, Inc. (LBR) was founded in 2001 by Lois B. Rosenberger, Ph.D., and Steve Rosenberger, J.D., with the belief that experienced professionals, operating within a hands-on and agile environment, could deliver higher-quality regulatory and clinical services more efficiently than larger, more administratively burdened organizations. From its inception, LBR focused on providing practical, cost-effective regulatory and clinical trial management solutions tailored to each client’s specific development needs. This commitment to quality and flexibility has resulted in long-standing client relationships, repeat engagements, and referrals from pharmaceutical, biotechnology, and medical device companies ranging from early-stage startups to mid-sized organizations lacking in-house regulatory and clinical infrastructure.
Innovative Analytics (IA) was established in 2003 by senior-level leaders from Pharmacia/Pfizer with a vision to deliver advanced statistical and data-driven expertise to support clinical development. IA built a highly specialized team of statisticians, programmers, and data management professionals, many holding advanced degrees in statistics or bringing more than a decade of industry experience. The company developed a strong reputation for delivering high-quality, timely analytical solutions supported by rigorous quality assurance and quality control processes. IA’s collaborative approach enabled seamless integration with sponsor teams and supported clinical programs from proof of concept through Phase III, with particular strength in data management, biostatistics, clinical programming, and medical writing.
After more than two decades of successful collaboration, LBR and Innovative Analytics merged to form LBRIA—a fully integrated, full-service Contract Research Organization (CRO).
The merger combines regulatory strategy, clinical trial management, data management, biostatistics, clinical programming, and medical writing under one organization, providing sponsors with a streamlined, end-to-end development partner. LBRIA offers the depth of expertise typically associated with larger CROs while maintaining the responsiveness, flexibility, and personalized service of a focused organization.